{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:30:32Z","timestamp":1792024232790,"version":"4.4.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T00:00:00Z","timestamp":1738972800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T00:00:00Z","timestamp":1738972800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004888","name":"Centre Hospitalier Universitaire de Qu\u00e9bec","doi-asserted-by":"publisher","award":["Centre Hospitalier Universitaire de Qu\u00e9bec"],"award-info":[{"award-number":["Centre Hospitalier Universitaire de Qu\u00e9bec"]}],"id":[{"id":"10.13039\/501100004888","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"DOI":"10.1007\/s00296-025-05804-8","type":"journal-article","created":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T04:16:47Z","timestamp":1738988207000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The association between polypharmacy and disease control in rheumatoid arthritis and systemic lupus erythematosus: a cohort study"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-7304-670X","authenticated-orcid":false,"given":"William","family":"Berthelot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3294-7883","authenticated-orcid":false,"given":"Caroline","family":"Sirois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Sophie","family":"Julien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Amiable","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6834-2731","authenticated-orcid":false,"given":"Louis","family":"Bessette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Desaulniers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Claude","family":"Audet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Lagac\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7278-2596","authenticated-orcid":false,"given":"Paul R.","family":"Fortin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,8]]},"reference":[{"key":"5804_CR1","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1186\/s12877-022-03279-x","volume":"22","author":"M Delara","year":"2022","unstructured":"Delara M, Murray L, Jafari B, Bahji A, Goodarzi Z, Kirkham J, Chowdhury Z, Seitz D (2022) Prevalence and factors associated with polypharmacy: a systematic review and meta-analysis. BMC Geriatr 22:601. https:\/\/doi.org\/10.1186\/s12877-022-03279-x","journal-title":"BMC Geriatr"},{"key":"5804_CR2","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s12877-017-0621-2","volume":"17","author":"N Masnoon","year":"2017","unstructured":"Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE (2017) What is polypharmacy? A systematic review of definitions. BMC Geriatr 17:230. https:\/\/doi.org\/10.1186\/s12877-017-0621-2","journal-title":"BMC Geriatr"},{"key":"5804_CR3","unstructured":"Gosselin E, Simard M, Dub\u00e9 M, Sirois C (2020) Portrait de la polypharmacie chez les a\u00een\u00e9s qu\u00e9b\u00e9cois entre 2000 et 2016. Institut national de sant\u00e9 publique du Qu\u00e9bec, Qu\u00e9bec; Gouvernement du Qu\u00e9bec. https:\/\/www.inspq.qc.ca\/sites\/default\/files\/publications\/2679_portrait_polypharmacie_aines_quebecois.pdf"},{"key":"5804_CR4","doi-asserted-by":"publisher","first-page":"e2800","DOI":"10.1590\/1518-8345.1316.2800","volume":"24","author":"MC Rodrigues","year":"2016","unstructured":"Rodrigues MC, Oliveira CD (2016) Drug-drug interactions and adverse drug reactions in polypharmacy among older adults: an integrative review. Rev Lat Am Enfermagem 24:e2800. https:\/\/doi.org\/10.1590\/1518-8345.1316.2800","journal-title":"Rev Lat Am Enfermagem"},{"issue":"4","key":"5804_CR5","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1111\/1475-6773.12562","volume":"52","author":"GE Miller","year":"2017","unstructured":"Miller GE, Sarpong EM, Davidoff AJ, Yang EY, Brandt NJ, Fick DM (2017) Determinants of potentially inappropriate medication use among community-dwelling older adults. Health Serv Res 52(4):1534\u20131549. https:\/\/doi.org\/10.1111\/1475-6773.12562","journal-title":"Health Serv Res"},{"issue":"8","key":"5804_CR6","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1097\/MLR.0000000000000171","volume":"52","author":"E Wallace","year":"2014","unstructured":"Wallace E, Stuart E, Vaughan N, Bennett K, Fahey T, Smith SM (2014) Risk prediction models to predict emergency hospital admission in community-dwelling adults. Med Care 52(8):751\u2013765. https:\/\/doi.org\/10.1097\/MLR.0000000000000171","journal-title":"Med Care"},{"issue":"6","key":"5804_CR7","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.japh.2017.06.002","volume":"57","author":"N Leelakanok","year":"2017","unstructured":"Leelakanok N, Holcombe AL, Bund BC, Gu X, Schweizer ML (2017) Association between polypharmacy and death: a systematic review and meta-analysis. J Am Pharm Assoc 57(6):729\u2013738. https:\/\/doi.org\/10.1016\/j.japh.2017.06.002","journal-title":"J Am Pharm Assoc"},{"issue":"1","key":"5804_CR8","doi-asserted-by":"publisher","first-page":"7683","DOI":"10.1038\/s41598-020-64732-8","volume":"10","author":"N Ziade","year":"2020","unstructured":"Ziade N, El Khoury B, Zoghbi M, Merheb G, Abi Karam G, Mroue\u2019 K, Messaykeh J (2020) Prevalence and pattern of comorbidities in chronic rheumatic and musculoskeletal diseases: the COMORD study. Sci Rep 10(1):7683. https:\/\/doi.org\/10.1038\/s41598-020-64732-8","journal-title":"Sci Rep"},{"key":"5804_CR9","doi-asserted-by":"publisher","first-page":"573542","DOI":"10.3389\/fmed.2020.573542","volume":"7","author":"JD Jack","year":"2020","unstructured":"Jack JD, McCutchan R, Maier S, Schirmer M (2020) Polypharmacy in Middle-European rheumatoid arthritis-patients: a retrospective longitudinal cohort analysis with systematic literature review. Front Med 7:573542. https:\/\/doi.org\/10.3389\/fmed.2020.573542","journal-title":"Front Med"},{"issue":"10","key":"5804_CR10","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1093\/rheumatology\/kez037","volume":"58","author":"K Bechman","year":"2019","unstructured":"Bechman K, Clarke BD, Rutherford AI, Yates M, Nikiphorou E, Molokhia M, Norton S, Cope AP, Hyrich KL, Galloway JB (2019) Polypharmacy is associated with treatment response and serious adverse events: results from the British society for rheumatology biologics register for rheumatoid arthritis. Rheumatology 58(10):1767\u20131776. https:\/\/doi.org\/10.1093\/rheumatology\/kez037","journal-title":"Rheumatology"},{"issue":"12","key":"5804_CR11","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.3899\/jrheum.160818","volume":"44","author":"M Filkova","year":"2017","unstructured":"Filkova M, Carvalho J, Norton S, Scott D, Mant T, Molokhia M, Cope A, Galloway J (2017) Polypharmacy and unplanned hospitalizations in patients with rheumatoid arthritis. J Rheumatol 44(12):1786\u20131793. https:\/\/doi.org\/10.3899\/jrheum.160818","journal-title":"J Rheumatol"},{"issue":"1","key":"5804_CR12","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s42358-018-0021-0","volume":"58","author":"MD Louren\u00e7o","year":"2018","unstructured":"Louren\u00e7o MD, Carli FV, De Assis MR (2018) Characterization of falls in adults with established rheumatoid arthritis and associated factors. Adv Rheumatol 58(1):16. https:\/\/doi.org\/10.1186\/s42358-018-0021-0","journal-title":"Adv Rheumatol"},{"issue":"3","key":"5804_CR13","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1080\/14397595.2020.1812200","volume":"31","author":"K Oh","year":"2021","unstructured":"Oh K, Furuya T, Ikari K, Inoue E, Tanaka E, Yamanaka H, Okazaki K, Harigai M (2021) Polypharmacy, declined walking speed, bent back, and disability associated with a history of falls in Japanese patients with rheumatoid arthritis: results from the IORRA cohort study. Mod Rheumatol 31(3):764\u2013767. https:\/\/doi.org\/10.1080\/14397595.2020.1812200","journal-title":"Mod Rheumatol"},{"issue":"8","key":"5804_CR14","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1097\/RHU.0000000000000463","volume":"22","author":"LM Gonz\u00e1lez-Gamboa","year":"2016","unstructured":"Gonz\u00e1lez-Gamboa LM, Barocio-Ram\u00edrez AK, Rocha-Mu\u00f1oz AD, De Santos-\u00c1vila F, Meda-Lara RM, Gonz\u00e1lez-L\u00f3pez L, G\u00e1mez-Nava JI, G\u00f3mez-Ba\u00f1uelos E, Chavarria-Avila E, Dur\u00e1n-Barrag\u00e1n S, Navarro-Hern\u00e1ndez RE, Pizano-Mart\u00ednez OE, Nu\u00f1ez-Atahualpa L, del V\u00e1zquez- M (2016) Disease activity score on 28 joints and polypharmacy are independent predictors for health-related quality of life evaluated by INCAVISA in patients with rheumatoid arthritis. J Clin Rheumatol 22(8):399\u2013404. https:\/\/doi.org\/10.1097\/RHU.0000000000000463","journal-title":"J Clin Rheumatol"},{"issue":"2","key":"5804_CR15","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1002\/acr.24766","volume":"75","author":"DJ S\u00e9guin","year":"2023","unstructured":"S\u00e9guin DJ, Peschken CA, Dolovich C, Grymonpre RE, St. John PD, Tisseverasinghe A (2023) Polypharmacy and potentially inappropriate medication use in older adults with systemic lupus erythematosus. Arthritis Care Res 75(2):356\u2013364. https:\/\/doi.org\/10.1002\/acr.24766","journal-title":"Arthritis Care Res"},{"issue":"6","key":"5804_CR16","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1136\/ard.2007.084459","volume":"68","author":"GA Wells","year":"2009","unstructured":"Wells GA, Becker JC, Teng J, Dougados M, Schiff M, Smolen JS, Aletaha D, Van Riel P (2009) Validation of the 28-joint disease activity score (DAS28) and European League against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate. Ann Rheum Dis 68(6):954\u2013960. https:\/\/doi.org\/10.1136\/ard.2007.084459","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"5804_CR17","doi-asserted-by":"publisher","first-page":"R796","DOI":"10.1186\/ar1740","volume":"7","author":"D Aletaha","year":"2005","unstructured":"Aletaha D, Nell V, Stamm T, Uffmann M, Pflugbeil S, Machold K, Smolen JS (2005) Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score. Arthritis Res Ther 7(4):R796\u2013806. https:\/\/doi.org\/10.1186\/ar1740","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"5804_CR18","first-page":"288","volume":"29","author":"DD Gladman","year":"2002","unstructured":"Gladman DD, Iba\u00f1ez D, Urowitz MB (2002) Systemic lupus erythematosus disease activity index 2000. J Rheumatol 29(2):288\u2013291","journal-title":"J Rheumatol"},{"issue":"1","key":"5804_CR19","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1002\/art.23238","volume":"59","author":"J Yazdany","year":"2008","unstructured":"Yazdany J, Yelin EH, Panopalis P, Trupin L, Juli\u00e1n L, Katz PP (2008) Validation of the systemic lupus erythematosus activity questionnaire in a large observational cohort. Arthritis Rheum 59(1):136\u2013143. https:\/\/doi.org\/10.1002\/art.23238","journal-title":"Arthritis Rheum"},{"issue":"5","key":"5804_CR20","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie C (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373\u2013383. https:\/\/doi.org\/10.1016\/0021-9681(87)90171-8","journal-title":"J Chronic Dis"},{"issue":"11","key":"5804_CR21","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/0895-4356(94)90129-5","volume":"47","author":"M Charlson","year":"1994","unstructured":"Charlson M, Szatrowski TP, Peterson J, Gold J (1994) Validation of a combined comorbidity index. J Clin Epidemiol 47(11):1245\u20131251. https:\/\/doi.org\/10.1016\/0895-4356(94)90129-5","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"5804_CR22","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s40545-021-00385-w","volume":"14","author":"D Prieto-Merino","year":"2021","unstructured":"Prieto-Merino D, Mulick A, Armstrong C, Hoult H, Fawcett S, Eliasson L, Clifford S (2021) Estimating proportion of days covered (PDC) using real-world online medicine suppliers\u2019 datasets. J Pharm Policy Pract 14(1):113. https:\/\/doi.org\/10.1186\/s40545-021-00385-w","journal-title":"J Pharm Policy Pract"},{"issue":"6","key":"5804_CR23","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1007\/s00296-019-04264-1","volume":"39","author":"I Coskun Benlidayi","year":"2019","unstructured":"Coskun Benlidayi I (2019) Polypharmacy in geriatric rheumatology. Rheumatol Int 39(6):1115\u20131116. https:\/\/doi.org\/10.1007\/s00296-019-04264-1","journal-title":"Rheumatol Int"},{"issue":"9","key":"5804_CR24","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1007\/s10067-023-06646-0","volume":"42","author":"H Miyake","year":"2023","unstructured":"Miyake H, Sada RM, Akebo H, Tsugihashi Y, Hatta K (2023) Prevalence and factors associated with polypharmacy among patients with rheumatoid arthritis: a single-centre, cross-sectional study. Clin Rheumatol 42(9):2287\u20132295. https:\/\/doi.org\/10.1007\/s10067-023-06646-0","journal-title":"Clin Rheumatol"},{"issue":"12","key":"5804_CR25","doi-asserted-by":"publisher","first-page":"3615","DOI":"10.1007\/s10067-022-06307-8","volume":"41","author":"Y Khader","year":"2022","unstructured":"Khader Y, Beran A, Ghazaleh S, Lee-Smith W, Altorok N (2022) Predictors of remission in rheumatoid arthritis patients treated with biologics: a systematic review and meta-analysis. Clin Rheumatol 41(12):3615\u20133627. https:\/\/doi.org\/10.1007\/s10067-022-06307-8","journal-title":"Clin Rheumatol"},{"issue":"10","key":"5804_CR26","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1093\/rheumatology\/ket224","volume":"52","author":"VK Ranganath","year":"2013","unstructured":"Ranganath VK, Maranian P, Elashoff D, Woodworth T, Khanna D, Hahn TJ, Sarkisian CA, Kremer JM, F\u00fcrst DE, Paulus HE (2013) Comorbidities are associated with poorer outcomes in community patients with rheumatoid arthritis. Rheumatology 52(10):1809\u20131817. https:\/\/doi.org\/10.1093\/rheumatology\/ket224","journal-title":"Rheumatology"},{"issue":"11","key":"5804_CR27","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1007\/s00296-022-05124-1","volume":"42","author":"I Yoshii","year":"2022","unstructured":"Yoshii I, Sawada N, Chijiwa T (2022) Clinical characteristics and variants that predict prognosis of difficult-to-treat rheumatoid arthritis. Rheumatol Int 42(11):1947\u20131954. https:\/\/doi.org\/10.1007\/s00296-022-05124-1","journal-title":"Rheumatol Int"},{"issue":"11","key":"5804_CR28","doi-asserted-by":"publisher","first-page":"5247","DOI":"10.1093\/rheumatology\/keab209","volume":"60","author":"S Takanashi","year":"2021","unstructured":"Takanashi S, Kaneko Y, Takeuchi T (2021) Characteristics of patients with difficult-to-treat rheumatoid arthritis in clinical practice. Rheumatology 60(11):5247\u20135256. https:\/\/doi.org\/10.1093\/rheumatology\/keab209","journal-title":"Rheumatology"},{"issue":"Suppl5","key":"5804_CR29","doi-asserted-by":"publisher","first-page":"v29","DOI":"10.1093\/rheumatology\/keaa382","volume":"59","author":"L Arnaud","year":"2020","unstructured":"Arnaud L, Tektonidou MG (2020) Long-term outcomes in systemic lupus erythematosus: trends over time and major contributors. Rheumatology 59(Suppl5):v29\u2013v38. https:\/\/doi.org\/10.1093\/rheumatology\/keaa382","journal-title":"Rheumatology"},{"key":"5804_CR30","unstructured":"D\u00e9sir\u00e9 Diend\u00e9r\u00e9 RJ, Jean S, Sirois C (2021) La polypharmacie chez les adultes qu\u00e9b\u00e9cois de moins de 65 ans assur\u00e9s par le r\u00e9gime public d\u2019assurance m\u00e9dicaments du Qu\u00e9bec (RPAM): description et analyse. Master\u2019s thesis, Universit\u00e9 Laval"},{"key":"5804_CR31","doi-asserted-by":"publisher","first-page":"e16418","DOI":"10.7717\/peerj.16418","volume":"11","author":"M Kara","year":"2023","unstructured":"Kara M, Alp G, Palanbek Yava\u015f S, Ta\u015fdemir A, Ketenci S, Kara MM, Ozduran E (2023) The effect of polypharmacy on rheumatoid and psoriatic arthritis treatment: retrospective study. PeerJ 11:e16418. https:\/\/doi.org\/10.7717\/peerj.16418","journal-title":"PeerJ"},{"issue":"28","key":"5804_CR32","doi-asserted-by":"publisher","first-page":"e205","DOI":"10.3346\/jkms.2024.39.e205","volume":"39","author":"GJ Kim","year":"2024","unstructured":"Kim GJ, Lee JS, Jang S, Lee S, Jeon S, Lee S, Kim JH, Lee KH (2024) Polypharmacy and elevated risk of severe adverse events in older adults based on the Korea Institute of drug safety and risk management-korea adverse event reporting system database. J Korean Med Sci 39(28):e205. https:\/\/doi.org\/10.3346\/jkms.2024.39.e205","journal-title":"J Korean Med Sci"},{"key":"5804_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/20420986241309882","volume":"15","author":"A Campeau Calfat","year":"2024","unstructured":"Campeau Calfat A, Turner JP, Simard M, Boiteau V, Sirois C (2024) Association between number of medications and indicators of potentially inappropriate polypharmacy: a population-based cohort of older adults in Quebec, Canada. Ther Adv Drug Saf 15:1\u201317. https:\/\/doi.org\/10.1177\/20420986241309882","journal-title":"Ther Adv Drug Saf"},{"issue":"2","key":"5804_CR34","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jamda.2019.10.022","volume":"21","author":"LE Davies","year":"2020","unstructured":"Davies LE, Spiers G, Kingston A, Todd A, Adamson J, Hanratty B (2020) Adverse outcomes of polypharmacy in older people: systematic review of reviews. J Am Med Dir Assoc 21(2):181\u2013187. https:\/\/doi.org\/10.1016\/j.jamda.2019.10.022","journal-title":"J Am Med Dir Assoc"},{"key":"5804_CR35","doi-asserted-by":"publisher","first-page":"101811","DOI":"10.1016\/j.arr.2022.101811","volume":"83","author":"JJ Toh","year":"2023","unstructured":"Toh JJ, Zhang H, Soh YY, Zhang Z, Wu XV (2023) Prevalence and health outcomes of polypharmacy and hyperpolypharmacy in older adults with frailty: a systematic review and meta-analysis. Ageing Res Rev 83:101811. https:\/\/doi.org\/10.1016\/j.arr.2022.101811","journal-title":"Ageing Res Rev"},{"issue":"7","key":"5804_CR36","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1002\/acr.24596","volume":"73","author":"L Fraenkel","year":"2021","unstructured":"Fraenkel L, Bathon JM, England BR, St Clair EW, Arayssi T, Carandang K, Deane KD, Genovese MC, Huston K, Kerr GS, Kremer JM, Nakamura MC, Russell L, Singh JA, Smith BJ, Sparks JA, Venkatachalam S, Weinblatt ME, Al-Gibbawi M, Akl EA et al (2021) 2021 American College of Rheumatology Guideline for the treatment of rheumatoid arthritis. Arthritis Care Res 73(7):924\u2013939. https:\/\/doi.org\/10.1002\/acr.24596","journal-title":"Arthritis Care Res"},{"issue":"1","key":"5804_CR37","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1136\/ard-2022-223356","volume":"82","author":"JS Smolen","year":"2022","unstructured":"Smolen JS, Landew\u00e9 R, Bergstra SA, Kerschbaumer A, Sepriano A, Aletaha D, Caporali R, Edwards CJ, Hyrich KL, Pope J, De Souza S, Stamm T, Takeuchi T, Verschueren P, Winthrop K, Balsa A, Bathon JM, Buch MH, Burmester GR, Van Der Heijde D et al (2022) EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update. Ann Rheum Dis 82(1):3\u201318. https:\/\/doi.org\/10.1136\/ard-2022-223356","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"5804_CR38","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1136\/annrheumdis-2019-215089","volume":"78","author":"A Fanouriakis","year":"2019","unstructured":"Fanouriakis A, Kostopoulou M, Alunno A, Aringer M, Bajema IM, Boletis J, Cervera R, Doria A, Gordon C, Govoni M, Houssiau F, Jayne D, Kouloumas M, Kuhn A, Larsen JL, Lerstr\u00f8m K, Moroni G, Mosca M, Schneider M, Boumpas DT et al (2019) 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. Ann Rheum Dis 78(6):736\u2013745. https:\/\/doi.org\/10.1136\/annrheumdis-2019-215089","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"5804_CR39","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1586\/eci.12.23","volume":"8","author":"BJF Van Den Bemt","year":"2012","unstructured":"Van Den Bemt BJF, Zwikker H, Van Den Ende C (2012) Medication adherence in patients with rheumatoid arthritis: a critical appraisal of the existing literature. Expert Rev Clin Immunol 8(4):337\u2013351. https:\/\/doi.org\/10.1586\/eci.12.23","journal-title":"Expert Rev Clin Immunol"},{"issue":"3","key":"5804_CR40","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.berh.2013.07.001","volume":"27","author":"N Costedoat-Chalumeau","year":"2013","unstructured":"Costedoat-Chalumeau N, Pouchot J, Guettrot-Imbert G, Guern VL, Leroux G, Marra D, Morel N, Piette J (2013) Adherence to treatment in systemic lupus erythematosus patients. Best Pract Res Clin Rheumatol 27(3):329\u2013340. https:\/\/doi.org\/10.1016\/j.berh.2013.07.001","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"8","key":"5804_CR41","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1007\/s00296-021-04898-0","volume":"41","author":"C Hardy","year":"2021","unstructured":"Hardy C, Gladman DD, Su J, Rozenbojm N, Urowitz MB (2021) Barriers to medication adherence and degree of nonadherence in a systemic lupus erythematosus (SLE) outpatient population. Rheumatol Int 41(8):1457\u20131464. https:\/\/doi.org\/10.1007\/s00296-021-04898-0","journal-title":"Rheumatol Int"},{"issue":"11","key":"5804_CR42","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1007\/s00296-016-3566-4","volume":"36","author":"PK Wong","year":"2016","unstructured":"Wong PK (2016) Medication adherence in patients with rheumatoid arthritis: why do patients not take what we prescribe? Rheumatol Int 36(11):1535\u20131542. https:\/\/doi.org\/10.1007\/s00296-016-3566-4","journal-title":"Rheumatol Int"},{"issue":"5","key":"5804_CR43","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1080\/03009740902932835","volume":"38","author":"B Rintelen","year":"2009","unstructured":"Rintelen B, Sautner J, Haindl P, Andel I, Maktari A, Leeb B (2009) Comparison of three rheumatoid arthritis disease activity scores in clinical routine. Scand J Rheumatol 38(5):336\u2013341. https:\/\/doi.org\/10.1080\/03009740902932835","journal-title":"Scand J Rheumatol"},{"issue":"1","key":"5804_CR44","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1093\/mr\/roac155","volume":"34","author":"H Miyake","year":"2023","unstructured":"Miyake H, Sada RM, Akebo H, Tsugihashi Y, Hatta K (2023) Polypharmacy prevalence and associated factors in patients with systemic lupus erythematosus: a single-centre, cross-sectional study. Mod Rheumatol 34(1):106\u2013112. https:\/\/doi.org\/10.1093\/mr\/roac155","journal-title":"Mod Rheumatol"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-025-05804-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-025-05804-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-025-05804-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T15:15:05Z","timestamp":1742656505000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-025-05804-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,8]]},"references-count":44,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["5804"],"URL":"https:\/\/doi.org\/10.1007\/s00296-025-05804-8","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,8]]},"assertion":[{"value":"13 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article was written without the use of artificial intelligence and has not been reviewed by a commercial editing service.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Use of artificial intelligence"}},{"value":"An earlier version of the abstract before final analysis was presented at the Canadian Rheumatology Association 2023 Annual Scientific Meeting: Berthelot W, Sirois C, Julien AS, Amiable N, Fortin PR (2023) Polypharmacy in Systemic Autoimmune Rheumatic Diseases. Canadian Rheumatology Association Meeting Quebec City Convention Centre Quebec City, Quebec, Canada February 8\u201311, 2023. J Rheumatol 50(7 Suppl 1):7-100. .","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Congress abstract publication"}}],"article-number":"44"}}